http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105193726-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 2015-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105193726-B |
| titleOfInvention | A kind of pharmaceutical composition for treating onychomycosis |
| abstract | The invention provides a kind of pharmaceutical composition for treating onychomycosis.The pharmaceutical composition of the onychomycosis forms in parts by weight：1 15 parts of active component Terbinafine, 1 15 parts of bifonazole, 15 60 parts of capsule material, 5 50 parts of hydration medium, 10 80 parts of purified water.The pharmaceutical composition vesicle solution envelop rate for the treatment of onychomycosis obtained by the present invention is high, transmission rates are fast, solve onychomycosis patient because the keratoprotein of nail plate is thick, cause to adhere to the problem of superincumbent fungi can not kill, it is rapid-action, safe and reliable, the great prospect of marketing. |
| priorityDate | 2015-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.